Dr. Lal PathLabs Board meeting scheduled on April 30, 2026 to approve Q4 and FY26 audited financial results.
Trading window for company securities will remain closed from April 1 to May 2, 2026 (both days inclusive).
Disclosure filed under Regulation 29 of SEBI (LODR) Regulations, 2015 by Company Secretary Vinay Gujral.